Cargando…

High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display

Most therapeutic antibodies (Abs) target cell surface proteins on tumor and immune cells. Cloning of Ab gene libraries in E. coli and their display on bacteriophages is commonly used to select novel therapeutic Abs binding target antigens, either purified or expressed on cells. However, the sticky n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salema, Valencio, Mañas, Carmen, Cerdán, Lidia, Piñero-Lambea, Carlos, Marín, Elvira, Roovers, Rob C., Van Bergen en Henegouwen, Paul M.P., Fernández, Luis Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058628/ https://www.ncbi.nlm.nih.gov/pubmed/27472381 http://dx.doi.org/10.1080/19420862.2016.1216742

Ejemplares similares

Escherichia coli surface display for the selection of nanobodies
por: Salema, Valencio, et al.
Publicado: (2017)

Facile labelling of an anti-epidermal growth factor receptor Nanobody with (68)Ga via a novel bifunctional desferal chelate for immuno-PET
por: Vosjan, Maria J. W. D., et al.
Publicado: (2011)

Specific tumor targeting and activation of Vγ9Vδ2 T cells by bi-specific nanobodies
por: Stam, Anita, et al.
Publicado: (2014)

Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy
por: Mashayekhi, Vida, et al.
Publicado: (2020)

Selection of Single Domain Antibodies from Immune Libraries Displayed on the Surface of E. coli Cells with Two β-Domains of Opposite Topologies
por: Salema, Valencio, et al.
Publicado: (2013)

A Nanobody‐on‐Quantum Dot Displacement Assay for Rapid and Sensitive Quantification of the Epidermal Growth Factor Receptor (EGFR)
por: Su, Ruifang, et al.
Publicado: (2022)

ssDNA recombineering boosts in vivo evolution of nanobodies displayed on bacterial surfaces
por: Al-ramahi, Yamal, et al.
Publicado: (2021)

Structural insights into the non-inhibitory mechanism of the anti-EGFR EgB4 nanobody
por: Zeronian, Matthieu R., et al.
Publicado: (2022)

Nanobody-Displaying Flagellar Nanotubes
por: Klein, Ágnes, et al.
Publicado: (2018)

Eps15: a multifunctional adaptor protein regulating intracellular trafficking
por: van Bergen en Henegouwen, Paul MP
Publicado: (2009)

ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand-binding
por: Low-Nam, Shalini T., et al.
Publicado: (2011)

Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice
por: Xenaki, Katerina T, et al.
Publicado: (2021)

Construction of a Nanobodies Phage Display Library From an Escherichia coli Immunized Dromedary
por: Salhi, Imed, et al.
Publicado: (2020)

Probing cytoskeletal modulation of passive and active intracellular dynamics using nanobody-functionalized quantum dots
por: Katrukha, Eugene A., et al.
Publicado: (2017)

Nanobody-targeted photodynamic therapy for the treatment of feline oral carcinoma: a step towards translation to the veterinary clinic
por: Beltrán Hernández, Irati, et al.
Publicado: (2021)

Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
por: Serrano-Rivero, Yunier, et al.
Publicado: (2023)

Homology Modeling-Based in Silico Affinity Maturation Improves the Affinity of a Nanobody
por: Cheng, Xin, et al.
Publicado: (2019)

Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
por: Caljon, Guy, et al.
Publicado: (2012)

Multifaceted Activities of Seven Nanobodies against Complement C4b
por: De la O Becerra, Karla I., et al.
Publicado: (2022)

Resolving bundled microtubules using anti-tubulin nanobodies
por: Mikhaylova, Marina, et al.
Publicado: (2015)

Correction: Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
por: Caljon, Guy, et al.
Publicado: (2012)

Evaluation of the yeast surface display system for screening of functional nanobodies
por: Kajiwara, Kaho, et al.
Publicado: (2020)

Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session
por: Deken, Marion M., et al.
Publicado: (2020)

Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer
por: van Brussel, Aram S. A., et al.
Publicado: (2015)

Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library
por: Yan, Junrong, et al.
Publicado: (2015)

EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer
por: van Driel, Pieter B.A.A., et al.
Publicado: (2016)

Yeast surface display platform for rapid discovery of conformationally selective nanobodies
por: McMahon, Conor, et al.
Publicado: (2018)

An improved yeast surface display platform for the screening of nanobody immune libraries
por: Uchański, Tomasz, et al.
Publicado: (2019)

A nanobody:GFP bacterial platform that enables functional enzyme display and easy quantification of display capacity
por: Wendel, Sofie, et al.
Publicado: (2016)

Construction of a T7 phage display nanobody library for bio-panning and identification of chicken dendritic cell-specific binding nanobodies
por: Xu, Hai, et al.
Publicado: (2022)

High-affinity anti-Arc nanobodies provide tools for structural and functional studies
por: Markússon, Sigurbjörn, et al.
Publicado: (2022)

Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells
por: Goyvaerts, C, et al.
Publicado: (2012)

Structure-based design and construction of a synthetic phage display nanobody library
por: Moreno, Ernesto, et al.
Publicado: (2022)

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging
por: de Bruijn, Henriette S., et al.
Publicado: (2020)

A Light‐Activatable Photocaged Variant of the Ultra‐High Affinity ALFA‐Tag Nanobody
por: Jedlitzke, Benedikt, et al.
Publicado: (2022)

Design of nanobody-based bispecific constructs by in silico affinity maturation and umbrella sampling simulations
por: Bai, Zixuan, et al.
Publicado: (2022)

Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment
por: Zettl, Ines, et al.
Publicado: (2022)

Modeling and affinity maturation of an anti-CD20 nanobody: a comprehensive in-silico investigation
por: Poustforoosh, Alireza, et al.
Publicado: (2023)

Programming Controlled Adhesion of E. coli to Target Surfaces, Cells, and Tumors with Synthetic Adhesins
por: Piñero-Lambea, Carlos, et al.
Publicado: (2014)

Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors
por: Hambach, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0k0c091mq8te64pgak434ume2r